NCT00069082已完成3 期
A Phase III, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multicenter Evaluation of Civamide (Zucapsaicin) Nasal Solution in the Treatment of Episodic Cluster Headache
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 2
- 试验地点
- 6
研究概览
简要总结
This is a 49-day study to evaluate the effectiveness of Intranasal Civamide (Zucapsaicin) in the treatment of an episodic cluster headache period compared to placebo (medically inactive substance which does not contain any active ingredients).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Civamide
Active Comparator
Nasal Solution 0.01%
干预措施: Civamide (Zucapsaicin) (Drug)
Placebo
Placebo Comparator
Placebo nasal solution with sodium chloride 10%
干预措施: Sodium Chloride (Drug)
研究者
研究点 (6)
Loading locations...
相似试验
已完成
3 期
A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster HeadacheEpisodic Cluster HeadacheNCT00033839Winston Laboratories60
尚未招募
3 期
Civamide Nasal Solution for Cluster HeadacheEpisodic Cluster HeadacheNCT01341548Winston Laboratories180
已完成
2 期
Acute Treatment Trial in Adult Subjects With MigrainesMigraineNCT03872453Pfizer2,154
已完成
2 期
Intranasal Capsaicin Treatment for Non-Allergic Irritant RhinitisNonallergic Irritant RhinitisNCT02493257The University of Texas Health Science Center, Houston22
已完成
3 期
A Study to Evaluate Efficacy and Safety of a Single Application of Capsaicin 8%Transdermal Delivery System Compared to Placebo in Reducing Pain Intensity in Subjects With Painful Diabetic Peripheral Neuropathy (PDPN)PainDiabetic Peripheral NeuropathyNCT01533428Astellas Pharma Inc369